Literature DB >> 2503252

Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

C Murre1, P S McCaw, H Vaessin, M Caudy, L Y Jan, Y N Jan, C V Cabrera, J N Buskin, S D Hauschka, A B Lassar.   

Abstract

A DNA binding and dimerization motif, with apparent amphipathic helices (the HLH motif), has recently been identified in various proteins, including two that bind to immunoglobulin enhancers (E12 and E47). We show here that various HLH proteins can bind as apparent heterodimers to a single DNA motif and also, albeit usually more weakly, as apparent homodimers. The HLH domain can mediate heterodimer formation between either daughterless, E12, or E47 (Class A) and achaete-scute T3 or MyoD (Class B) to form proteins with high affinity for the kappa E2 site in the immunoglobulin kappa chain enhancer. The achaete-scute T3 and MyoD proteins do not form kappa E2-binding heterodimers together, and no active complex with N-myc was evident. The formation of a heterodimer between the daughterless and achaete-scute T3 products may explain the similar phenotypes of mutants at these two loci and the genetic interactions between them. A role of E12 and E47 in mammalian development, analogous to that of daughterless in Drosophila, is likely.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503252     DOI: 10.1016/0092-8674(89)90434-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  561 in total

1.  Degradation of MyoD by the ubiquitin pathway: regulation by specific DNA-binding and identification of a novel site for ubiquitination.

Authors:  A Ciechanover; K Breitschopf; O A Hatoum; E Bengal
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

2.  Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.

Authors:  T Kophengnavong; J E Michnowicz; T K Blackwell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 4.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Authors:  M Kitzmann; M Vandromme; V Schaeffer; G Carnac; J C Labbé; N Lamb; A Fernandez
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.

Authors:  A Polesskaya; I Naguibneva; A Duquet; E Bengal; P Robin; A Harel-Bellan
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  Isolation and characterization of the activated B-cell factor 1 homolog in Caenorhabditis elegans.

Authors:  L Nguyen; J Round; R O'Connell; P Geurts; M Funes-Duran; J Wong; G Jongeward; C A Vierra
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

8.  Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells.

Authors:  K J Vincent; E Jones; M J Arthur; D E Smart; J Trim; M C Wright; D A Mann
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 9.  A genetic investigation of E2A function in lymphocyte development.

Authors:  J Hanrahan; L Pan; S Greenbaum; C Bradney; M Hjelmeland; M Dai; Y Zhuang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

10.  Identification of Id2 as a globin regulatory protein by representational difference analysis of K562 cells induced to express gamma-globin with a fungal compound.

Authors:  M L Holmes; J D Haley; L Cerruti; W L Zhou; H Zogos; D E Smith; J M Cunningham; S M Jane
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.